Santhera Pharmaceuticals Holding AG (SPHDF)
19.79
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Santhera Pharmaceuticals Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| BeOne Medicines Ltd. | -6.128M |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | 7.18M |
| Idorsia Ltd. | 38.69M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow | -43.53M |
| Free Cash Flow Yield | -16.81% |